Statistics

Total Visits

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials79

Select a period of time:

Number of views in the range

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials56

Views

Views
March 202513
April 202512
May 20256
June 202515
July 20257
August 20251
September 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore34
Hong Kong10
Brazil5
United States3
Argentina1
Spain1
United Kingdom1
Guatemala1
 

Top cities views

Views
Hong Kong10
Arealva1
Council Bluffs1
Dallas1
Guatemala City1
Hull1
Itaperuna1
Missouri City1
Piraquara1
Porto Alegre1